Skip to main content

Want a detailed portfolio tracker?

Chimerix (CMRX) Revenue (2013 - 2024)

Chimerix (CMRX) revenue from Jun 30, 2013 to Dec 31, 2024. The TTM Chimerix (CMRX) revenue is $220K. You can adjust inflation or export chart.

Annual Revenue

Quarterly Revenue

Chimerix (CMRX) Revenue CAGR table

PeriodCAGR
1 Year TTM-31.25%
3 Years TTM-52.01%
5 Years TTM-73.19%
10 Years TTM-25.27%
All Time TTM-23.13%

Annual Revenue change of Chimerix (CMRX)

YearRevenueChange
2024$210K-34.38%
2023$320K-99.05%
2022$34M+1608.08%
2021$1.98M-63.13%
2020$5.37M-57.11%
2019$13MN/A
2018$0N/A
2017$0N/A
2016$0-100.00%
2015$11M+166.34%
2014$4.04M-7.55%
2013$4.37MN/A

Comparison Chimerix (CMRX) five years revenue CAGR with competitors

Chimerix (CMRX) five years revenue CAGR is -54.73%.

TickerNamefive years Revenue CAGRUpside
BEAMBeam Therapeutics Inc484.70%-985.62%
RYTMRhythm Pharmaceuticals Inc473.51%-965.18%
CRMDCorMedix Inc336.16%-714.22%
TGTXTG Therapeutics Inc278.04%-608.03%
GERNGeron Corp257.04%-569.65%
RVNCRevance Therapeutics Inc216.35%-495.30%
FENCFennec Pharmaceuticals Inc202.90%-470.74%
IBRXImmunityBio Inc200.12%-465.65%
ASNDAscendis Pharma A/S175.66%-420.95%
VXRTVaxart Inc174.17%-418.23%
SNDXSyndax Pharmaceuticals Inc169.88%-410.39%
AAPGAscentage Pharma Group International160.77%-393.75%
OCGNOcugen Inc153.09%-379.71%
BBIOBridgeBio Pharma Inc131.56%-340.38%
PRTAProthena Corporation plc131.47%-340.21%
CTXRCitius Pharmaceuticals Inc128.54%-334.87%
TLXTelix Pharmaceuticals Ltd127.76%-333.44%
PRQRProQR Therapeutics N.V121.71%-322.37%
BOLTBolt Biotherapeutics Inc121.10%-321.27%
PLURPluri Inc115.90%-311.77%
RPTXRepare Therapeutics Inc114.08%-308.45%
ATHEAlterity Therapeutics Ltd111.91%-304.47%
VRDNViridian Therapeutics Inc111.57%-303.85%
MRSNMersana Therapeutics Inc109.71%-300.46%
FHTXFoghorn Therapeutics Inc108.52%-298.28%
ARDXArdelyx Inc101.30%-285.08%
ARGXArgen X SE98.17%-279.37%
SEERSeer Inc - Class A94.78%-273.17%
ABUSArbutus Biopharma Corp90.98%-266.23%
GYREGyre Therapeutics Inc80.86%-247.74%
ENSCEnsysce Biosciences Inc79.79%-245.80%
TARSTarsus Pharmaceuticals Inc74.12%-235.43%
LEGNLegend Biotech Corp70.27%-228.40%
ADAGAdagene Inc61.38%-212.14%
CVACCureVac N.V.60.56%-210.64%
ADMAAdma Biologics Inc60.37%-210.30%
RXRXRecursion Pharmaceuticals Inc - Class A59.35%-208.44%
CGENCompugen Ltd57.53%-205.12%
ADAPAdaptimmune Therapeutics plc American Depositary Shares55.42%-201.26%
LCTXLineage Cell Therapeutics Inc54.06%-198.77%
CUECue Biopharma Inc53.77%-198.24%
MRKRMarker Therapeutics Inc53.28%-197.35%
IDYAIdeaya Biosciences Inc53.10%-197.01%
TRAWTraws Pharma Inc51.20%-193.56%
ALNYAlnylam Pharmaceuticals Inc49.77%-190.94%
FDMT4D Molecular Therapeutics Inc49.16%-189.82%
ZLABZai Lab Ltd49.02%-189.56%
URGNUroGen Pharma Ltd48.76%-189.10%
ARWRArrowhead Pharmaceuticals Inc47.49%-186.77%
ONCBeiGene Ltd46.08%-184.20%
ARCTArcturus Therapeutics Holdings Inc43.41%-179.31%
AUPHAurinia Pharmaceuticals Inc42.37%-177.41%
BCYCBicycle Therapeutics Plc41.82%-176.41%
XBIOXenetic Biosciences Inc41.05%-175.00%
MNKDMannkind Corp40.31%-173.65%
ZVRAZevra Therapeutics Inc39.30%-171.80%
BRTXBioRestorative Therapies Inc38.99%-171.24%
IMRNImmuron Ltd38.57%-170.48%
MGTXMeiraGTx Holdings plc37.98%-169.39%
CPRXCatalyst Pharmaceuticals Inc37.80%-169.07%
HRMYHarmony Biosciences Holdings Inc37.73%-168.94%
INSMInsmed Inc37.33%-168.21%
HALOHalozyme Therapeutics Inc35.42%-164.71%
WVEWave Life Sciences Ltd35.16%-164.25%
APLSApellis Pharmaceuticals Inc34.55%-163.13%
ARVNArvinas Inc33.48%-161.17%
MESOMesoblast Ltd32.03%-158.52%
NBTXNanobiotix31.49%-157.54%
CRSPCRISPR Therapeutics AG30.10%-154.99%
SRPTSarepta Therapeutics Inc26.94%-149.23%
ANABAnaptysBio Inc26.67%-148.74%
VRCAVerrica Pharmaceuticals Inc25.37%-146.35%
LXRXLexicon Pharmaceuticals Inc24.38%-144.54%
TVTXTravere Therapeutics Inc22.05%-140.29%
RANIRani Therapeutics Holdings Inc Class A21.08%-138.51%
FOLDAmicus Therapeutics Inc19.44%-135.52%
GLPGGalapagos NV19.11%-134.91%
ACADAcadia Pharmaceuticals Inc19.04%-134.78%
DYAIDyadic International Inc DE19.03%-134.76%
OCULOcular Therapeutix Inc18.64%-134.06%
EXELExelixis Inc18.17%-133.20%
VCELVericel Corp17.77%-132.47%
CORTCorcept Therapeutics Inc17.73%-132.39%
TNGXTango Therapeutics Inc17.63%-132.22%
RIGLRigel Pharmaceuticals17.49%-131.96%
NAGENiagen Bioscience Inc16.96%-130.98%
PTGXProtagonist Therapeutics Inc16.30%-129.77%
RAREUltragenyx Pharmaceutical Inc14.93%-127.28%
INCYIncyte Corp14.68%-126.82%
STROSutro Biopharma Inc14.67%-126.81%
MRUSMerus N.V14.54%-126.56%
PTCTPTC Therapeutics Inc13.95%-125.50%
VRTXVertex Pharmaceuticals Inc13.75%-125.13%
CELUCelularity Inc - Class A13.21%-124.13%
JAZZJazz Pharmaceuticals plc12.75%-123.29%
HRTXHeron Therapeutics Inc12.60%-123.03%
CYTKCytokinetics Inc12.56%-122.96%
BMRNBiomarin Pharmaceutical Inc11.94%-121.82%
NTRBNutriband Inc11.86%-121.68%
PHARPharming Group N.V.11.69%-121.37%
OPTOpthea Ltd11.41%-120.85%
SPROSpero Therapeutics Inc11.22%-120.50%
TBPHTheravance Biopharma Inc10.63%-119.42%
ABVCABVC BioPharma Inc10.50%-119.19%
REGNRegeneron Pharmaceuticals Inc10.16%-118.56%
NRIXNurix Therapeutics Inc9.95%-118.19%
DAREDare Bioscience Inc9.62%-117.58%
MDXGMimedx Group Inc9.58%-117.50%
VALNValneva SE9.35%-117.08%
CSBRChampions Oncology Inc9.14%-116.69%
IONSIonis Pharmaceuticals Inc8.38%-115.32%
CYCNCyclerion Therapeutics Inc8.20%-114.98%
LGNDLigand Pharmaceuticals Inc - Class B8.15%-114.88%
FBIOFortress Biotech Inc8.13%-114.86%
AGENAgenus Inc7.88%-114.40%
ABEOAbeona Therapeutics Inc7.77%-114.20%
MGNXMacrogenics Inc7.76%-114.19%
PLXProtalix BioTherapeutics Inc7.76%-114.17%
TECHBio-Techne Corp7.39%-113.50%
EVGNEvogene Ltd7.27%-113.29%
CRDFCardiff Oncology Inc7.25%-113.24%
JAGXJaguar Health Inc7.22%-113.20%
CLLSCellectis6.98%-112.75%
CASICASI Pharmaceuticals Inc6.66%-112.18%
IGCIGC Pharma Inc6.63%-112.11%
ACIUAC Immune SA6.29%-111.48%
DTILPrecision Biosciences Inc6.03%-111.01%
CRBPCorbus Pharmaceuticals Holdings Inc5.98%-110.93%
KPTIKaryopharm Therapeutics Inc5.95%-110.87%
NTLAIntellia Therapeutics Inc5.11%-109.33%
IVAInventiva4.71%-108.60%
DNAGinkgo Bioworks Holdings Inc - Class A4.63%-108.45%
XOMAXOMA Royalty Corp4.58%-108.37%
INVAInnoviva Inc4.13%-107.54%
ACRSAclaris Therapeutics Inc4.08%-107.45%
IMMPImmutep Ltd3.96%-107.23%
PGENPrecigen Inc3.45%-106.31%
IMTXImmatics N.V3.26%-105.96%
VTGNVistaGen Therapeutics Inc3.10%-105.66%
XNCRXencor Inc2.91%-105.31%
RPRXRoyalty Pharma plc - Class A2.82%-105.16%
ICCCImmucell Corp2.75%-105.02%
BNTXBioNTech SE2.17%-103.96%
LSTALisata Therapeutics Inc1.86%-103.41%
CDXSCodexis Inc1.52%-102.78%
HYFTMindWalk Holdings Corp1.38%-102.53%
KYMRKymera Therapeutics Inc0.86%-101.58%
ALECAlector Inc0.42%-100.76%